ISR Immune System Regulation Holding AB (publ), vidare kallat ”ISR”, är ett publikt bolag med ca 14 500 aktieägare.
ISR har fyra dotterbolag som bedriver forskning inom HIV, HVB, Onkologi, Covid-19 samt andra infektionssjukdomar, i huvudsak genom kapitalinjektioner från ISR Holding.
En resa mot ett samhälle utan HIV och Vaccinering utan sprutor.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Stockholm, Stockholms Län 10234, Se
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Stockholm, Stockholms län
Isr Immune System Regulation Holding Ab (Publ) Questions
Isr Immune System Regulation Holding Ab (Publ)'s LinkedIn profile is https://se.linkedin.com/company/isr-immune-system-regulation-holding-ab-publ
Isr Immune System Regulation Holding Ab (Publ) has
2 employees.
View email and phone details for 2
employees at Isr Immune System Regulation Holding Ab (Publ).
Isr Immune System Regulation Holding Ab (Publ)'s industry is
Biotechnology Research
Isr Immune System Regulation Holding Ab (Publ)'s top competitors are
Binvestock Holding Ab,
K A & P Holding Ab,
J Lodhi Holding Ab,
Ipsiac Holding Ab,
Qbr Systems Ab,
Promech Lab Holding Ab -Team,
Tamarama Holding,
Mastery Holding Ab,
Holding Relations,
Immune System Regulation Ab.
Isr Immune System Regulation Holding Ab (Publ)'s categories are Biotechnology Research
Isr Immune System Regulation Holding Ab (Publ)'s founding year is 2008
